DSM halves the carbon footprint of Akulon® PA6

DSM halves the carbon footprint of Akulon® PA6. (Photos: DSM Engineering Materials: DSMPR521)Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announces that its Engineering Materials will offer its existing Akulon® PA6 portfolio produced in Europe with a significantly reduced carbon footprint by the beginning of 2021, thus offering the lowest carbon footprint of PA6 available in the market. This enables DSM’s customers to reduce the carbon footprint of their own products and contribute to the global reduction of greenhouse gas emissions.

Clariant introduces static reducing
compounds for drug delivery devices

Dry Powder Inhalers (DPI) are complex devices and rely on consistent flow through the device mouthpiece. Static charges resulting in powder build up can interfere with dose reliability. (Photo: Clariant)Clariant Plastics & Coatings Healthcare Polymer Solutions recently launched static-reducing functional plastic compounds which, when used in drug delivery devices, enable increased dose reliability. The resins are part of the wider ‘medical grade’ MEVOPUR® line of color and additive concentrates and ‘ready-to-use’ polymer compounds, covering polymers from PE to PEEK.

Metal 3D printing helps New Zealand Defence Force veteran on his Invictus Games journey

Additively manufactured cleat positioned between shoe and pedal on Stevin Creegan’s race bike.
(Photo: GE Additive, GEADPR040)Ten years after a helicopter crash changed air force veteran, Stevin Creeggan’s life. Now a team of New Zealand Defence Force engineers is using additive manufacturing to help change it again.

Archroma to join the moulding and millwork producers association (MMPA)

Rodrigo Casa Grande, Head of Sales for Packaging, Paper & Wood, North America, Archroma. (Photo: Archroma)Archroma, a global leader in color and specialty chemicals towards sustainable solutions, today announced that it has joined the US-based Moulding & Millwork Producers Association (MMPA).

Clariant’s new Hostatint SI relieves tinting reformulation challenges for North American industrial coatings manufacturers

Color shift (due to flocculation of pigment particles) is prevalent in many solvent-borne pigment dispersions. Hostatint SI eliminates this unwanted characteristic and delivers consistent color for most industrial coatings. (Photo: Clariant)Constant color adjustments to industrial paint formulas are history! Clariant launches a new line of pigment dispersions engineered for exact color matching, reducing the time and costs related to batch-to-batch reformulations. This novel approach answers a direct need of formulators who work on industrial, automotive, maintenance and other demanding protective coatings. New Hostatint SI pigment dispersions address one of the top challenges for North American manufacturers of solvent-based paints and coatings, the majority of which are used in industrial applications.

Clariant doubles capacity of its high-throughput catalyst R&D center in Palo Alto

Sample preparation with a high-throughput robot in Clariant Catalysts’ expanded research center in Palo Alto, California. (Photo: Clariant)Clariant Catalysts is picking up speed with the successful expansion of its high-throughput R&D center in Palo Alto, California. Thanks to a significant investment, the upgraded facility is fitted with the latest high-throughput equipment, and will be home to an expanded team of technical experts. By doubling the research and development capacity of its Palo Alto facility, the company greatly strengthens its ability to offer faster and better solutions to its customers, and to support partners with custom catalyst scale-up projects.

Changes in INEOS Styrolution management

Kevin McQuade, Chairman at INEOS Styrolution.Kevin McQuade, who has led the company as Chief Executive Officer since January 1, 2015 has been appointed as Chairman of INEOS Styrolution.

MT Ortho harnesses additive technology to manufacture customized prostheses for cranioplasty and bone cancer patients

MT Ortho - kyphoplasty procedure.
(Photo: MT Ortho, GEADPR039)Until just a few years ago only standardized, conventionally manufactured prostheses - or in very limited cases customized prostheses - were available for patients with bone tumors.